The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis

The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis

Abstract Background Multi-matrix mesalazine (MMX) is an important treatment for ulcerative colitis (UC); however, it is often excreted intact, which increases the risk of relapse. This study aimed to clarify the risk factors for insoluble MMX excretion. Methods The subjects were 102 UC patients who...

Full description

Bibliographic Details
Main Authors: Ohtaki Yuichiro, Uchiyama Kan, Kamiya Hirotaka, Moriizumi Eri, Yamada Moe, Aoki Yuma, Watanabe Toshimune, Kiryu Sachie, Suzuki Sizuka, Matsumoto Yoshihiro, Ito Zensho, Ohkusa Toshifumi, Koido Shigeo, Saruta Masayuki
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Gastroenterology
Subjects:
Ulcerative Colitis
MMX
Bristol Stool Form Scale
5-ASA
Adherence
Multi-matrix system mesalazine
Online Access:https://doi.org/10.1186/s12876-022-02474-9

Internet

https://doi.org/10.1186/s12876-022-02474-9

Similar Items